Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Late-Stage Pipeline

50%

2 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

Phase 4
2(50.0%)
Phase 2
1(25.0%)
Early Phase 1
1(25.0%)
4Total
Phase 4(2)
Phase 2(1)
Early Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05921448Early Phase 1Active Not Recruiting

Vaccine Pandemic Preparedness Through Airway Immunology Characterization

Role: lead

NCT06892197Phase 4Recruiting

Comparing Hydrocortisone and Prednisolone for Community Acquired Pneumonia (CAP)

Role: lead

NCT06892210Phase 4Recruiting

Comparing Hydrocortisone and Prednisolone for Acute Exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD)

Role: lead

NCT06859450Phase 2Not Yet Recruiting

Local Antibiotic Delivery for Community Acquired Pneumonia

Role: lead

All 4 trials loaded